Towards neurotransplantation in multiple system atrophy: Clinical rationale, pathophysiological basis, and preliminary experimental evidence

Cell Transplantation

Volumn 9, Issue 2, 2000, Pages 279-288

  Wenning, Gregor Karl ^a   Tison, Francois ^b   Scherfler, Christoph ^a   Puschban, Zoe ^a   Waldner, Regina ^a   Granata, Roberta ^a   Ghorayeb, Imad ^b   Poewe, Werner ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b CNRS   (France)

Author keywords

Multiple system atrophy; Neurotransplantation

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; DOPAMINE; DOPAMINE RECEPTOR; LEVODOPA; OXIDOPAMINE; QUINOLINIC ACID; SUBSTANCE P;

ARTICLE; CORPUS STRIATUM; HUMAN; MITOCHONDRION; NERVOUS TISSUE; NEUROPROTECTION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RESPIRATORY CHAIN; SHY DRAGER SYNDROME; TRANSPLANTATION;

ANIMALIA; PRIMATES;

EID: 0034068074     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/096368970000900213     Document Type: Article

References (91)

1. Adams, R. D.; van Bogaert, L.; van der Ecken, H. Dégénérescences nigro-strieés et cérébello-nigro-strieés. Psychiatr. Neurol. 142:219-259; 1961.
2. Barker, R.; Dunnett, S. B. Ibotenic acid lesions of the striatum reduce drug-induced rotation in the 6-hydroxydopamine-lesioned rat. Exp. Brain. Res. 101:365-374; 1994.
3. Beal, M. F.; Brouillet, E.; Jenkins, B. G.; Ferrante, R. J.; Kowall, N. W.; Miller, J. M. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13:4181-4192; 1993.
4. Becker, J. B.; Freed, W. J. Adrenal medulla grafts enhance functional activity of the striatal dopamine system following substantia nigra lesions. Brain Res. 462:401-406; 1988.
5. Berciano, J. Olivopontocerebellar atrophy. A review of 117 cases. J. Neurol. Sci. 53:253-272; 1982.
6. Bezard, E.; Dovero, S.; Bioulac, B.; Gross, C. E. Kinetics of nigral degeneration in chronic model of MPTP treated mice. Neurosci. Lett. 234:47-50; 1997.
7. Bezard, E.; Imbert, C.; Gross, C. E. Experimental models of Parkinson's disease: From the static to the dynamic. Rev. Neurosci. 9:71-90; 1998.
8. 3H]mazindol autoradiography. Neuroscience 43:95-110; 1991.
9. 11C-raclopride and positron emission tomography. Ann. Neurol. 31:184-192; 1992.
10. Brouillet, E.; Hantraye, P. Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates. Curr. Opin. Neurol. 8:469-473; 1995.
11. Brundin, P.; Isacson, O.; Gage, F. H.; Björklund, A. Intrastriatal grafting of dopamine-containing neuronal cell suspensions: Effects of mixing with target or non-target cells. Brain Res. 389:77-84; 1986.
12. 11C] diprenorphine PET study. Brain 118:951-958; 1995.
13. Carpenter, M. B. Human neuroanatomy, 8th ed. Baltimore, MD: Williams and Wilkins; 1983.
14. 2 receptors. Ann. Neurol. 34:219-226; 1993.
15. Costantini, L. C.; Vozza, B. M.; Snyder-Keller, A. M. Enhanced efficacy of nigral-striatal cotransplants in bilaterally dopamine-depleted rats: An anatomical and behavioral analysis. Exp. Neurol. 127:219-231; 1994.
16. Costantini, L. C.; Snyder-Keller, A. Co-transplantation of fetal lateral ganglionic eminence and ventral mesencephalon can augment function and development of intrastriatal transplants. Exp. Neurol. 145:214-227; 1997.
17. Daniel, S. E. The neuropathology and neurochemistry of multiple system atrophy. In: Bannister, R.; Mathias, C. J., eds. A textbook of clinical disorders of autonomie nervous system. 3rd ed. Oxford: Oxford University Press; 1992: 564-585.
18. Dejerine, J.; Thomas, A. A.; L'atrophie olivo-ponto-cérébelleuse. Nouvelle Iconographie de la Salpêtrière 13:330-370; 1900.
19. Deutch, A. Y.; Rosin, D. L.; Goldstein, M.; Roth, R.H. 3-Acetylpyridine-induced degeneration of the nigrostriatal dopamine system: An animal model of olivopontocerebellar atrophy-associated parkinsonism. Exp. Neurol. 105: 1-9; 1989.
20. Deutch, A. Y.; Elsworth, J.D.; Roth, R. H.; Goldstein, M.; Deutsch, A. Y. 3-Acetylpyridine results in degeneration of the extrapyramidal and cerebellar motor systems: Loss of the dorsolateral striatal dopamine innervation. Brain Res. 527:96-102; 1990.
21. Dunnett, S. B.; Iversen, S. D. Sensorimotor impairment following localized kainic acid and 6-hydroxydopamine lesions of the striatum. Brain Res. 248:121-127; 1982.
22. Fearnley, J. M.; Lees, A. J. Striatonigral degeneration. A clinicopathological study. Brain 113:1823-1842; 1990.
23. Frim, D. M.; Uhler, T. A.; Galpern, W. R.; Beal, M. F.; Breakefield, X.O.; Isacson, O. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridium toxicity to dopaminergic neurons in the rat. Proc. Natl. Acad. Sci. USA 91:5104-5108; 1994.
24. Gilman, S.; Low, P. A.; Quinn, N. P.; Albanese, A.; Ben-Shlomo, Y.; Fowler, C. J. Consensus statement on the diagnosis of multiple system atrophy. J. Auton. Nerv. Syst. 74:189-192; 1998.
25. Goedert, M.; Spillantini, M. G. Lewy body disease and multiple system atrophy as alpha-synucleinopathies. Mol. Psychiatry 3:462-465; 1998.
26. Golbe, L. I. Alpha-synuclein and Parkinson's disease. Mov. Disord. 14:6-9; 1999.
27. Goto, S.; Hirano, A.; Matsumoto, S. Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and nigrostriatal degeneration. Ann. Neurol. 26: 766-770; 1989.
28. Goto, S.; Hirano, A.; Rojos-Corona, P. R. Immunohistochemical visualization of afferent nerve terminals in human globus pallidus and its alteration in neostriatal neurodegenerative disorders. Acta. Neuropathol. 78:543-550; 1989.
29. Goto, S.; Hirano, A.; Matsumoto, S. Met-enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degeneration. Neurology 40:1051-1056; 1990.
30. Goto, S.; Matsumoto, J.; Ushio, Y.; Hirano, A. Subregional loss of putaminal efferents to the basal ganglia output nuclei may cause parkinsonism in striatonigral degeneration. Neurology 47:1032-36; 1996.
31. Gould, D. H.; Gustine, D. L. Basal ganglia degeneration, myelin alterations, and enzyme inhibition induced in mice by the plant toxin 3-nitropropanoic acid. Neuropathol. Appl. Neurobiol. 8:377-393; 1982.
32. Graham, J. G.; Oppenheimer, D. R. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 32:28-34; 1969.
33. Hagell, P.; Schrag, A.; Piccini, P.; Jahanshahi, M.; Brown, R.; Rehncrona, S. Sequential bilateral transplantation in Parkinson's disease: Effects of a second graft. Brain (in press).
34. Hefti, F.; Melamed, E.; Sahakian, B. J.; Wurtman, R. J. Circling behaviour in rats with partial, unilateral nigrostriatal lesions, effect of amphetamine, apomorphine, and L-dopa. Pharmacol. Biochem. Behav. 12:185-188; 1980.
35. Hughes, A. J.; Daniel, S. E.; Kilford, L.; Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55:181-184; 1992.
36. Ito, H., Kusaka, H.; Matsumoto, S.; Imai, T. Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy. Neurology 47: 1291-1299; 1996.
37. Kirik, D.; Rosenblad, C.; Björklund, A. Characterization of behavioural and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp. Neurol. 152:259-277; 1998.
38. Kish, S. J.; Shannak, K.; Hornykiewicz, O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: Pathologic and clinical implications. N. Engl. J. Med. 318:876-880; 1988.
39. Kume, A.; Takahashi, A.; Hashizume, Y. Neuronal cell loss of the striatonigral system in multiple system atrophy. J. Neurol. Sci. 117:33-40; 1993.
40. Lang, A. E.; Lozano, A. M.; Montgomery, E.; Duff, J.; Tasker, R.; Hutchinson, W. Posteroventral medial pallidotomy in advanced Parkinson's disease. N. Engl. J. Med. 337:1036-1042 1997.
41. Lang, A. E.; Lozano, A. M. Parkinson's disease: Second of two parts. N. Engl. J. Med. 339:1130-1143; 1998.
42. Lantos, P. L.; Papp, M. I. Cellular pathology of multiple system atrophy : A review. J. Neurol. Neurosurg. Psychiatry 57:129-133; 1994.
43. Lantos, P. L. The definition of multiple system atrophy: A review of recent developments. J. Neuropathol. Exp. Neurol. 57:1099-1111; 1998.
44. Levivier, M.; Gash, D. M.; Przedborski, S. Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum. Neuroscience 69:43-50; 1995.
45. Limousin, P.; Krack, P.; Pollack, P.; Benazzouz, A.; Aradouin, C.; Hoffman, C. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med. 339:1105-1111; 1998.
46. Ludwin, S. L. The pathobiology of the oligodendrocyte. J. Neuropathol. Exp. Neurol. 56:11-124; 1997.
47. Montoya, C. P.; Campbell-Hope, L. J.; Pemberton, K. D.; Dunnett, S. B. The "staircase test": A measure of independent forelimb reaching and grasping abilities in rats. J. Neurosci. Methods 36(2-3):219-228; 1991.
48. Nakao, N.; Brundin, P. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid. Neuroscience 76:749-761; 1997.
49. Olanow, C. W.; Kordower, J. H.; Freeman, T. B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19:102-109; 1996.
50. Olsson, M.; Nikkhah, G.; Bentlage, C.; Björklund, A. Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci. 15:3863-3875; 1995.
51. Papp, M. I.; Kahn, J. E.; Lantos, P. L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J. Neurol. Sci. 94:79-100; 1989.
52. Papp, M. I.; Lantos, P. L. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J. Neurol. Sci. 107: 172-182; 1992.
53. Papp, M. I.; Lantos, P. L. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 117:235-243; 1994.
54. Parati, E. A.; Tetoni, G.C.; Geminiani, P.; Soliveri, P.; Giovannini, P.; Testa, D. Response to L-dopa in multiple system atrophy. Clin. Neuropharmacol. 16:139-144; 1993.
55. Peschanski, M.; Cesaro, P.; Hantraye, P. What is needed versus what would be interesting to know before undertaking neural transplantation in patients with Huntington's disease. Neuroscience 71:899-900; 1996.
56. Probst-Cousin, S.; Rickert, C. H.; Schmid, K. W.; Gullotta, F. Cell death mechanisms in mutiple sysytem atrophy. J. Neuropathol. Exp. Neurol. 57:814-821; 1998.
57. 2 receptor densities in a rat model of multiple system atrophy and the influence of embryonic allografts. Soc. Neurosci. Abstr. 24: 1988; 1998.
58. 3H] mazindol autoradiography (abstract). J. Neural Transm. (in press).
59. Pycock, C. J.; Marsden, C. D. The rotating rodent: A two component system? Eur. J. Pharmacol. 47:167-175; 1978.
60. 3H] spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease. J. Neurol. Sci. 43:429-437; 1979.
61. Quinn, N. P.; Marsden, C. D. The motor disorder of multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 56: 1239-1242; 1993.
62. Quinn, N. P. Multiple system atrophy. In: Marsden, C. D.; Fahn, S., eds. Movement disorders 3. London: Butterworth-Heinemann; 1994:262-281.
63. Rajput, A. H.; Rozdilsky, B.; Rajput, A.; Ang, L. Levodopa efficacy and pathological basis of Parkinson syndrome. Clin. Neuropharmacol. 13:553-558; 1990.
64. Sauer, H.; Oertel, W. H. Progressive degeneration of nigrostriatal dopaminergic neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59:401-415; 1994.
65. 123I-IBZM-SPECT. Mov. Disord. 8:453-458; 1993.
66. Scherfler, C.; Wenning, G. K.; Puschban, Z.; Weiler, B.; Poewe, W. Striatal neuroprotection in a double lesion animal model of striatonigral degeneration (abstract). J. Neural Transm. (in press).
67. Schmidt, R. H.; Björklund, A.; Stenevi, U.; Gage, F. H. Intracerebral grafting of neuronal cell suspensions. III Activity of intrastriatal nigral suspension implants as assessed by measurement of dopamine synthesis and metabolism. Acta Physiol. Scand. Suppl. 522:19-29; 1983.
68. Schulz, J. B.; Henshaw, D. R.; Jenkins, B. G.; Ferrante, R. J.; Kowall, N.W.; Rosen, B. R. 3-Acetylpyridine produces age-dependent excitotoxic lesions in the rat striatum. J. Cereb. Blood Flow Metab. 14:1024-1029; 1994.
69. Schwarz, J.; Tatsch, K.; Arnold, G.; Gasser, T.; Trenkwalder, C.; Kirsch, C. M. 123-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism. Neurology 42:556-561; 1992.
70. Schwarz, J.; Weis, S.; Kraft, E.; Tatsch, K.; Bandmann, O.; Mehraein, P.; Vogl. T. Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putumen of two patients with multiple system atrophy. J. Neurol. Neurosurg. Psychiatry. 60:98-101; 1996.
71. Schwarz, S. C.; Seufferlein, T.; Liptay, S.; Schmid, R. M.; Kasischke, K.; Foster, O. J. F. Microglial activation in multiple system atrophy: A potential role for NF-κB/rel proteins. Neuroreport 9:3029-3032; 1998.
72. 1 receptors in Parkinson's disease and striatonigral degeneration: A positron emission tomography study. J. Neurol. Neurosurg. Psychiatry 56:467-472; 1993.
73. Shy, G. M.; Draeger, G. A. A neurological syndrome associated with orthostatic hypotension. Arch. Neurol. 2: 511-527; 1960.
74. Spencer, D. D.; Robbins, R. J.; Naftolin, F.; Marek, K. L.; Vollmer, T.; Leranth, C. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients wilh Parkinson's disease. N. Engl. J. Med. 327: 1541-1548; 1992.
75. Spillantini, M. G.; Schmidt, M. L.; Lee, V. M.; Trojanowski, J. Q.; Jakes, R.; Goedert, M. Alpha-synuclein in Lewy bodies. Nature 388:839-840; 1997.
76. Srivastava, R.; Brouillet, E.; Beal, M. F.; Storey, E.; Hyman, B. T. Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: A stereological estimate of neuronal loss. Neurobiol. Aging 14:295-301; 1993.
77. Storey, E.; Hyman, B. T.; Jenkins, B.; Brouillet, E.; Miller, J. M.; Rosen, B. R. 1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism. J. Neurochem. 58: 1975-1978; 1992.
78. Takada, M.; Kono, T. 3-Acetylpyridine neurotoxicity to the nigrostriatal dopamine system in mice. Neurosci. Lett. 161:211-214; 1993.
79. Tison, F.; Wenning, G. K.; Daniel, S.E.; Quinn, N. P. The pathophysiology of parkinsonism in multiple sytem atrophy. Eur. J. Neurol. 2:435-444; 1995.
80. Vonsattel, J. P.; Myers, M. H.; Stevens, T. J.; Ferrante, R. J.; Bird, E. D.; Richardson, E. P. Neuropathological classification of Huntington's disease. J. Neuropath. Exp. Neurol. 44:559-577; 1985.
81. Wenning, G. K.; Ben-Shlomo, Y.; Magalhaes, M.; Daniel, S. E.; Quinn, N. P. Clinical features and natural history of multiple system atrophy. Brain 117:835-845; 1994.
82. Wenning, G. K.; Quinn, N.; Magalhaes, M.; Mathias, C.; Daniel, S. E. "Minimal change" multiple sytem atrophy. Mov. Disord. 9:161-166; 1994.
83. Wenning, G. K.; Granata, R.; Laboyrie, P. M.; Quinn, N. P.; Jenner, P.; Marsden, C. D. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. Mov. Disord. 11:522-532; 1996.
84. Wenning, G. K.; Laboyrie, P.; Granata, R.; Quinn, N. P.; Jenner, P.; Marsden, C. D. Reversal of behavioural abnormalities in a rat model of striatonigral degeneration following intrastriatal transplantation of pure mesencephalic and mesencephalic-striatal co-grafts. Mov. Disord. 11:44; 1996.
85. Wenning, G. K.; Tison, F.; Ben-Shlomo, Y.; Daniel, S. E.; Quinn, N. P. Multiple system atrophy: A review of 203 pathologically proven cases. Mov. Disord. 12:133-147; 1997.
86. Wenning, G. K.; Odin, P.; Morrish, P.; Rehncrona, S.; Widner, H.; Brundin, P. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42:95-107; 1997.
87. 123I-IBZM SPECT. J. Neural Transm. Suppl. (in press).
88. Wenning, G. K.; Waldner, R.; Puschban, Z.; Scherfler, C.; Poewe, W. A novel neural transplantation model of striatonigral degeneration using 3-nitropropionic acid (abstract). J. Neural Transm. (in press).
89. Winn, P.; Stone, T. W.; Latimer, M.; Hastings, M. H.; Clark, A. J. A comparison of excitotoxic lesions of the basal forebrain by kainate, quinolinate, ibotenate, N-methyl-D-aspartate or quisqualate, and the effect on toxicity of 2-amino-5-phosphonovaleric acid and kynurenic acid in the rat. Br. J. Pharmacol. 102:904-908; 1991.
90. Wuellner, U.; Weller, N.; Groscurth, P.; Loschmann, P. A.; Schulz, J. B.; Müller, I. Evidence for an active type of cell death with ultrastructural features distinct from apoptosis: The effects of 3-acetylpyridine neurotoxicity. Neuroscience 81:721-734; 1997.
91. Yurek, D. M.; Collier, T. J.; Sladek, J. R. Embryonic mesencephalic and striatal co-grafts: Development of grafted dopamine neurons and functional recovery. Exp. Neurol. 109:191-199; 1990.